600557 康缘药业
已收盘 08-23 15:00:00
资讯
新帖
简况
康缘药业:产品取得注册证
每日经济新闻 · 08-24 00:07
康缘药业:产品取得注册证
康缘药业最新公告:获得温阳解毒颗粒药品注册证书
证券之星 · 08-23 17:50
康缘药业最新公告:获得温阳解毒颗粒药品注册证书
康缘药业08月23日主力资金流出230万元 连续5日减仓
市场透视 · 08-23 15:17
康缘药业08月23日主力资金流出230万元 连续5日减仓
康缘药业(600557)8月21日主力资金净卖出888.77万元
证券之星 · 08-22 08:24
康缘药业(600557)8月21日主力资金净卖出888.77万元
康缘药业08月21日主力资金流出863万元 连续3日减仓
自选股智能写手 · 08-21
康缘药业08月21日主力资金流出863万元 连续3日减仓
康缘药业(600557)8月19日主力资金净卖出1474.85万元
证券之星 · 08-20
康缘药业(600557)8月19日主力资金净卖出1474.85万元
康缘药业:参股公司是防止猴痘疫情传入复核试剂盒采购项目中标单位
E公司 · 08-19
康缘药业:参股公司是防止猴痘疫情传入复核试剂盒采购项目中标单位
康缘药业(600557)8月16日主力资金净买入1962.18万元
证券之星 · 08-17
康缘药业(600557)8月16日主力资金净买入1962.18万元
康缘药业: 根据《药品注册管理办法》审评时限要求,优先审评审批程序的审评时限为一百三十个工作日
证星董秘互动 · 08-16
康缘药业: 根据《药品注册管理办法》审评时限要求,优先审评审批程序的审评时限为一百三十个工作日
康缘药业08月15日遭主力抛售846万元 环比增加635.65%
自选股智能写手 · 08-15
康缘药业08月15日遭主力抛售846万元 环比增加635.65%
天风证券给予康缘药业买入评级
每日经济新闻 · 08-15
天风证券给予康缘药业买入评级
康缘药业(600557):业绩短期承压 合规建设下长期向好
天风证券股份有... · 08-15
康缘药业(600557):业绩短期承压 合规建设下长期向好
康缘药业(600557)8月14日主力资金净买入35.66万元
证券之星 · 08-15
康缘药业(600557)8月14日主力资金净买入35.66万元
675款中成药被取消挂网 涉康缘药业、亚宝药业等上市公司
新京报网 · 08-14
675款中成药被取消挂网 涉康缘药业、亚宝药业等上市公司
康缘药业: 公司2024年上半年存货增加主要系今年高温季节生产检修,提前储备库存所致
证星董秘互动 · 08-14
康缘药业: 公司2024年上半年存货增加主要系今年高温季节生产检修,提前储备库存所致
V观财报|股价已跌三成、业绩爆冷下滑,康缘药业说:“生产经营都是正常的”
中新经纬 · 08-13
V观财报|股价已跌三成、业绩爆冷下滑,康缘药业说:“生产经营都是正常的”
康缘药业(600557):短期利润有所扰动 关注销售复苏节奏
招商证券股份有... · 08-13
康缘药业(600557):短期利润有所扰动 关注销售复苏节奏
康缘药业大幅上涨 中药餐饮市场火爆
智选洞察 · 08-12
康缘药业大幅上涨 中药餐饮市场火爆
江苏中药研发一哥,五年烧27亿,开始破防
E药经理人 · 08-11
江苏中药研发一哥,五年烧27亿,开始破防
康缘药业(600557)8月9日主力资金净卖出759.95万元
证券之星 · 08-10
康缘药业(600557)8月9日主力资金净卖出759.95万元
公司概况
公司名称:
江苏康缘药业股份有限公司
所属行业:
医药制造业
上市日期:
2002-09-18
主营业务:
江苏康缘药业股份有限公司主要业务药品的研发、生产与销售。公司主要产品线聚焦病毒感染性疾病、妇科疾病、心脑血管疾病、骨伤科疾病等中医优势领域,病毒感染性疾病产品线的代表品种有热毒宁注射液、金振口服液、杏贝止咳颗粒等;妇科产品线的代表品种有桂枝茯苓胶囊、散结镇痛胶囊等;心脑血管产品线的代表品种有银杏二萜内酯葡胺注射液、天舒胶囊、龙血通络胶囊、益心舒片、大株红景天胶囊、苁蓉总苷胶囊等;骨伤科产品线的代表品种有腰痹通胶囊、复方南星止痛膏、淫羊藿总黄酮胶囊、抗骨增生胶囊等;同时还拥有治疗小儿多发性抽动症的九味熄风颗粒等儿科专用药品。公司是国家技术创新示范企业、国家重点高新技术企业、国家创新型试点企业、国家知识产权示范企业,全国制药工业百强企业。
发行价格:
7.00
{"stockData":{"symbol":"600557","market":"SH","secType":"STK","nameCN":"康缘药业","latestPrice":12.75,"timestamp":1724396400000,"preClose":12.81,"halted":0,"volume":7672805,"delay":0,"floatShares":578000000,"shares":582000000,"eps":0.9049,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.06,"latestTime":"08-23 15:00:00","open":12.8,"high":12.99,"low":12.65,"amount":98036700,"amplitude":0.0265,"askPrice":12.76,"askSize":97,"bidPrice":12.75,"bidSize":29,"shortable":0,"etf":0,"ttmEps":0.9049,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":12.81,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":14.09,"lowLimit":11.53,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":581797452,"pbRate":1.44,"roa":"--","roe":"5.04%","epsLYR":0.93,"committee":-0.159839,"marketValue":7418000000,"floatMarketCap":7376000000,"peRate":14.089954,"changeRate":-0.0047,"turnoverRate":0.0133,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-08-26。"},"requestUrl":"/m/hq/s/600557/wiki","defaultTab":"wiki","newsList":[{"id":"2461351412","title":"康缘药业:产品取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2461351412","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461351412?lang=zh_cn&edition=full","pubTime":"2024-08-24 00:07","pubTimestamp":1724429265,"startTime":"0","endTime":"0","summary":"每经AI快讯,康缘药业 8月24日发布公告称,江苏康缘药业股份有限公司于近日收到国家药品监督管理局签发的温阳解毒颗粒《药品注册证书》。按照《上海证券交易所上市公司自律监管指引第3号——行业信息披露》的相关要求。2024年1至6月份,康缘药业的营业收入构成为:工业企业国内销售占比99.24%。道达号“个股趋势”提醒:1. 康缘药业近30日内北向资金持股量增加198.04万股,占流通股比例增加0.35%;2. 近30日内无机构对康缘药业进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082400081295b8c800&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082400081295b8c800&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","600557","BK0188","BK0239"],"gpt_icon":0},{"id":"2461568451","title":"康缘药业最新公告:获得温阳解毒颗粒药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2461568451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461568451?lang=zh_cn&edition=full","pubTime":"2024-08-23 17:50","pubTimestamp":1724406640,"startTime":"0","endTime":"0","summary":"康缘药业公告,公司近日收到国家药品监督管理局签发的温阳解毒颗粒《药品注册证书》。该药品是中药3.2类,为独家品种,具有温阳益气,化湿解毒的功效,用于疫病辨证属阳气虚弱,疫毒侵袭症见发热、咳嗽、胸闷等症状的患者治疗。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082300034861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600557","BK0239","BK0188"],"gpt_icon":0},{"id":"2461530762","title":"康缘药业08月23日主力资金流出230万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2461530762","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461530762?lang=zh_cn&edition=full","pubTime":"2024-08-23 15:17","pubTimestamp":1724397442,"startTime":"0","endTime":"0","summary":"08月23日, 康缘药业股价跌0.47%,报收12.75元,成交金额9803万元,换手率1.33%,振幅2.65%,量比0.55。康缘药业今日主力资金净流出230万元,连续5日净流出,上一交易日主力净流出490万元,今日环比减少53.06%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为63.64%,平均跌幅为2.68%。该股近5个交易日下跌8.41%,主力资金累计净流出5676万元;近20日主力资金累计净流出4630万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408231520549f4b1f66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408231520549f4b1f66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0188","600557","BK0239"],"gpt_icon":0},{"id":"2461389527","title":"康缘药业(600557)8月21日主力资金净卖出888.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461389527","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461389527?lang=zh_cn&edition=full","pubTime":"2024-08-22 08:24","pubTimestamp":1724286271,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月21日收盘,康缘药业报收于12.97元,下跌1.74%,换手率1.8%,成交量10.41万手,成交额1.36亿元。8月21日的资金流向数据方面,主力资金净流出888.77万元,占总成交额6.56%,游资资金净流入479.41万元,占总成交额3.54%,散户资金净流入409.36万元,占总成交额3.02%。近5日资金流向一览见下表:康缘药业融资融券信息显示,融资方面,当日融资买入705.95万元,融资偿还976.85万元,融资净偿还270.89万元。康缘药业主营业务:涉及药品的研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200007578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600557","BK0188","BK0239"],"gpt_icon":0},{"id":"2461182928","title":"康缘药业08月21日主力资金流出863万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2461182928","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461182928?lang=zh_cn&edition=full","pubTime":"2024-08-21 15:17","pubTimestamp":1724224636,"startTime":"0","endTime":"0","summary":"08月21日, 康缘药业股价跌1.74%,报收12.97元,成交金额1.36亿元,换手率1.80%,振幅2.27%,量比0.68。康缘药业今日主力资金净流出863万元,连续3日净流出,上一交易日主力净流出2182万元,今日环比减少60.45%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为52.38%,平均跌幅为2.30%。该股近5个交易日下跌5.19%,主力资金累计净流出3870万元;近20日主力资金累计净流出4096万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408211518509f40f1c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408211518509f40f1c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0188","BK0239","600557"],"gpt_icon":0},{"id":"2460940430","title":"康缘药业(600557)8月19日主力资金净卖出1474.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460940430","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460940430?lang=zh_cn&edition=full","pubTime":"2024-08-20 08:25","pubTimestamp":1724113520,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月19日收盘,康缘药业报收于13.61元,下跌2.23%,换手率3.07%,成交量17.76万手,成交额2.45亿元。8月19日的资金流向数据方面,主力资金净流出1474.85万元,占总成交额6.01%,游资资金净流入2770.73万元,占总成交额11.3%,散户资金净流出1295.88万元,占总成交额5.28%。近5日资金流向一览见下表:康缘药业融资融券信息显示,融资方面,当日融资买入1660.95万元,融资偿还1575.33万元,融资净买入85.62万元。康缘药业主营业务:涉及药品的研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000006084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","600557","BK0239"],"gpt_icon":0},{"id":"2460055485","title":"康缘药业:参股公司是防止猴痘疫情传入复核试剂盒采购项目中标单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2460055485","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460055485?lang=zh_cn&edition=full","pubTime":"2024-08-19 23:06","pubTimestamp":1724079960,"startTime":"0","endTime":"0","summary":"e公司讯,康缘药业在互动平台表示,据中国政府采购网近期公开信息查询,伯杰(青岛)医疗科技有限公司是上海国际旅行卫生保健中心(上海海关口岸门诊部)防止猴痘疫情传入复核试剂盒采购项目中标单位。按持股比例计算,公司间接持有伯杰(青岛)医疗科技有限公司0.3513%股份,该公司不属于公司主要子公司,也不会对公司经营产生重大影响,敬请投资者谨慎决策,注意投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819230641ab5e6e69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819230641ab5e6e69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600557","BK0239","BK0028","BK0188"],"gpt_icon":0},{"id":"2460276468","title":"康缘药业(600557)8月16日主力资金净买入1962.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460276468","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460276468?lang=zh_cn&edition=full","pubTime":"2024-08-17 08:14","pubTimestamp":1723853670,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月16日收盘,康缘药业报收于13.92元,上涨1.75%,换手率3.24%,成交量18.76万手,成交额2.6亿元。8月16日的资金流向数据方面,主力资金净流入1962.18万元,占总成交额7.55%,游资资金净流出636.14万元,占总成交额2.45%,散户资金净流出1326.03万元,占总成交额5.1%。近5日资金流向一览见下表:康缘药业融资融券信息显示,融资方面,当日融资买入2239.79万元,融资偿还2058.53万元,融资净买入181.26万元。康缘药业主营业务:涉及药品的研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081700012896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","600557"],"gpt_icon":0},{"id":"2459171213","title":"康缘药业: 根据《药品注册管理办法》审评时限要求,优先审评审批程序的审评时限为一百三十个工作日","url":"https://stock-news.laohu8.com/highlight/detail?id=2459171213","media":"证星董秘互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459171213?lang=zh_cn&edition=full","pubTime":"2024-08-16 20:01","pubTimestamp":1723809668,"startTime":"0","endTime":"0","summary":"证券之星消息,康缘药业08月16日在投资者关系平台上答复投资者关心的问题。根据《药品注册管理办法》审评时限要求,优先审评审批程序的审评时限为一百三十个工作日。龙七胶囊于2024年4月提交药品上市申请,进入优先审评审批程序,具体进展需以监管部门审批为准。相关事项若涉及信息披露事宜,公司会按照相关法律法规的要求及时公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816200426959eb894&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816200426959eb894&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600557","BK0188","BK0239","BK0028"],"gpt_icon":0},{"id":"2459419110","title":"康缘药业08月15日遭主力抛售846万元 环比增加635.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459419110","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459419110?lang=zh_cn&edition=full","pubTime":"2024-08-15 15:18","pubTimestamp":1723706300,"startTime":"0","endTime":"0","summary":"08月15日,康缘药业股价收平报13.68元,成交金额1.93亿元,换手率2.43%,振幅3.95%,量比0.97。康缘药业今日主力资金净流出846万元,连续3日净流出,上一交易日主力净流出115万元,今日环比增加635.65%。|08月15日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|凯旺科技|7.05%|#|海辰药业|6.01%|#|天舟文化|4.83%|#|世纪鼎利|4.49%|#|川润股份|4.16%|#|天利科技|3.92%|#|瀛通通讯|3.55%|#|正业科技|3.26%|#|国中水务|3.17%|#|华金资本|2.86%|康缘药业所在的中药Ⅱ行业,今日主力净流出9109万元,行业排名8/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151528259f2ceabf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151528259f2ceabf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0188","600557","BK0239"],"gpt_icon":0},{"id":"2459466751","title":"天风证券给予康缘药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2459466751","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459466751?lang=zh_cn&edition=full","pubTime":"2024-08-15 10:09","pubTimestamp":1723687749,"startTime":"0","endTime":"0","summary":"天风证券08月15日发布研报称,给予康缘药业(600557.SH,最新价:13.55元)买入评级。评级理由主要包括:1)经营短期承压,合规营销持续推进;2)盈利能力稳健,研发项目稳步推进。风险提示:产品销售不及预期风险,政策波动风险,销售改革不及预期风险。AI点评:康缘药业近一个月获得7份券商研报关注,买入7家,平均目标价为17.64元,与最新价13.55元相比,高4.09元,目标均价涨幅30.18%。文章来源:每日经济新闻原标题:天风证券给予康缘药业买入评级","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151019129599e410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151019129599e410&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601162","600557"],"gpt_icon":0},{"id":"2459864463","title":"康缘药业(600557):业绩短期承压 合规建设下长期向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2459864463","media":"天风证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459864463?lang=zh_cn&edition=full","pubTime":"2024-08-15 09:53","pubTimestamp":1723686837,"startTime":"0","endTime":"0","summary":"事件2024H1,公司实现营收22.60 亿元,同比-11.49%;归母净利润2.65 亿元同比-3.73%;扣非归母净利润2.21 亿元,同比-15.95%。2024H1,公司整体经验短期承压,主要系公司在全面合规建设推进和提升的过程中,面临内外部多重复杂环境和挑战,对短期经营业绩增速产生了一定的影响。但着眼未来,全面合规体系建设有助于实现企业各项业务长期健康发展。维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150954019599d342&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150954019599d342&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600557","BK0188","BK0239","BK0028"],"gpt_icon":0},{"id":"2459745167","title":"康缘药业(600557)8月14日主力资金净买入35.66万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459745167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459745167?lang=zh_cn&edition=full","pubTime":"2024-08-15 08:25","pubTimestamp":1723681549,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月14日收盘,康缘药业报收于13.68元,下跌2.22%,换手率1.91%,成交量11.05万手,成交额1.51亿元。8月14日的资金流向数据方面,主力资金净流入35.66万元,占总成交额0.24%,游资资金净流入391.89万元,占总成交额2.59%,散户资金净流出427.55万元,占总成交额2.82%。近5日资金流向一览见下表:康缘药业融资融券信息显示,融资方面,当日融资买入902.82万元,融资偿还1026.5万元,融资净偿还123.68万元。康缘药业主营业务:涉及药品的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500012962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600557","BK0028","BK0188"],"gpt_icon":0},{"id":"2459175757","title":"675款中成药被取消挂网 涉康缘药业、亚宝药业等上市公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2459175757","media":"新京报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459175757?lang=zh_cn&edition=full","pubTime":"2024-08-14 20:31","pubTimestamp":1723638660,"startTime":"0","endTime":"0","summary":"涵盖多个大品种在进行公示之后,河北省医用药品器械集中采购中心8月13日发布了不符合挂网条件的中成药和生物制剂名单,多达675款中成药被取消挂网。河北省此次公布名单,与2023年8月开始实施的中成药生物制剂规范挂网采购新规有关。康缘药业、亚宝药业等公司产品在列多家上市公司产品也出现在名单之中。与康缘药业情况相似,亚宝药业未在财报中披露这几款药品的销售情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814203218a1d44630&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814203218a1d44630&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0239","BK0077","BK0188","BK0028","600557","BK0201","600351"],"gpt_icon":0},{"id":"2459120625","title":"康缘药业: 公司2024年上半年存货增加主要系今年高温季节生产检修,提前储备库存所致","url":"https://stock-news.laohu8.com/highlight/detail?id=2459120625","media":"证星董秘互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459120625?lang=zh_cn&edition=full","pubTime":"2024-08-14 20:01","pubTimestamp":1723636865,"startTime":"0","endTime":"0","summary":"证券之星消息,康缘药业08月14日在投资者关系平台上答复投资者关心的问题。公司2024年上半年存货增加主要系今年高温季节生产检修,提前储备库存所致。具体详见公司于2024年7月27日在上海证券交易所网站披露的《2024年半年度报告》“第三节管理层讨论与分析”之“四、报告期内主要经营情况”。感谢您对公司的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081420025395985a27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081420025395985a27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","600557","BK0188","BK0028"],"gpt_icon":0},{"id":"2459921488","title":"V观财报|股价已跌三成、业绩爆冷下滑,康缘药业说:“生产经营都是正常的”","url":"https://stock-news.laohu8.com/highlight/detail?id=2459921488","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459921488?lang=zh_cn&edition=full","pubTime":"2024-08-13 17:06","pubTimestamp":1723540019,"startTime":"0","endTime":"0","summary":"(董文博)13日,国内中药创新龙头康缘药业低开低走,截至收盘跌3.18%,报价13.99元...","market":"us","thumbnail":"http://www.jwview.com/jingwei/08-13/U820P902T1D603895F10DT20240813171730.jpg","type":0,"news_type":0,"thumbnails":["http://www.jwview.com/jingwei/08-13/U820P902T1D603895F10DT20240813171730.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.jwview.com/jingwei/html/08-13/603895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zxjw_stock","symbols":["600557"],"gpt_icon":0},{"id":"2459917727","title":"康缘药业(600557):短期利润有所扰动 关注销售复苏节奏","url":"https://stock-news.laohu8.com/highlight/detail?id=2459917727","media":"招商证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459917727?lang=zh_cn&edition=full","pubTime":"2024-08-13 13:24","pubTimestamp":1723526680,"startTime":"0","endTime":"0","summary":"公司发布2024 年半年度报告,2024H1 实现营业收入22.60 亿元,同比下降11.49%;归母净利润2.65 亿元,同比下降3.73%;扣非归母净利润2.21 亿元,同比下降15.95%。其中2024Q2 实现营业收入9.01 亿元,同比下降24.98%,环比下降33.72%;归母净利润1.17 亿元,同比下降12.59%,环比下降20.71%;扣非归母净利润0.81 亿元,同比下降34.22%,环比下降41.96%。基于院内环境和公司自身调整因素,我们下调预计2024-2026 年归母净利润为5.4/6.5/7.6 亿元,同比增长0.7%/19.6%/17.1%,对应PE 为15/13/11 倍,维持“强烈推荐”投资评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813132443959437be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813132443959437be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600557","BK0028","BK0239","BK0188"],"gpt_icon":0},{"id":"2458864492","title":"康缘药业大幅上涨 中药餐饮市场火爆","url":"https://stock-news.laohu8.com/highlight/detail?id=2458864492","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458864492?lang=zh_cn&edition=full","pubTime":"2024-08-12 10:51","pubTimestamp":1723431071,"startTime":"0","endTime":"0","summary":"08月12日,康缘药业股价大幅上涨,截至10点51分,康缘药业上涨5.00%,报14.49元/股,成交1.79亿元,换手率2.18%,振幅5.51%。北向资金方面,康缘药业08月09日获得北向资金减持129.62万股,截至08月09日,北向资金当前共持有康缘药业2090.43万股,市值3.03亿元,持股占流通股比为3.61%。主营业务及业绩康缘药业公司主营业务为涉及药品的研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812105316af96fe1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812105316af96fe1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0028","600557","BK0188"],"gpt_icon":0},{"id":"2458678397","title":"江苏中药研发一哥,五年烧27亿,开始破防","url":"https://stock-news.laohu8.com/highlight/detail?id=2458678397","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458678397?lang=zh_cn&edition=full","pubTime":"2024-08-11 19:00","pubTimestamp":1723374043,"startTime":"0","endTime":"0","summary":"原因直指康缘药业上一周周五晚间发布的半年报,财报显示,2024年上半年,康缘药业营业总收入和扣非净利润双双下降,降幅均超过10%。“对中药注射剂建立科学的评价体系、包括研发,药学研究,工艺,质量标准,作用机理、安全试验、有效性等”早已被呼吁多年。2017年,国家医保目录正式对39个中药注射剂做出了严格的报销使用范围限制,其中26个临床常用的大品种均仅限二级以上医疗机构使用,并做了重症、病种的限制。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811190702958fdc3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811190702958fdc3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600557","BK0239","BK0188","BK0028"],"gpt_icon":0},{"id":"2458294115","title":"康缘药业(600557)8月9日主力资金净卖出759.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458294115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458294115?lang=zh_cn&edition=full","pubTime":"2024-08-10 08:20","pubTimestamp":1723249244,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月9日收盘,康缘药业报收于13.8元,下跌2.82%,换手率2.28%,成交量13.17万手,成交额1.84亿元。近5日资金流向一览见下表:康缘药业融资融券信息显示,融资方面,当日融资买入1840.23万元,融资偿还1050.83万元,融资净买入789.41万元,连续3日净买入累计1224.33万元。康缘药业主营业务:涉及药品的研发、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081000012867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600557","BK0028","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2002-09-18","address":"江苏省连云港市连云区经济技术开发区江宁工业城","stockEarnings":[{"period":"1week","weight":-0.0841},{"period":"1month","weight":-0.15},{"period":"3month","weight":-0.2686},{"period":"6month","weight":-0.2711},{"period":"1year","weight":-0.2633},{"period":"ytd","weight":-0.3652}],"companyName":"江苏康缘药业股份有限公司","boardCode":"AI0027","perCapita":"17577股","boardName":"医药制造业","registeredCapital":"58179万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":" 江苏康缘药业股份有限公司主要业务药品的研发、生产与销售。公司主要产品线聚焦病毒感染性疾病、妇科疾病、心脑血管疾病、骨伤科疾病等中医优势领域,病毒感染性疾病产品线的代表品种有热毒宁注射液、金振口服液、杏贝止咳颗粒等;妇科产品线的代表品种有桂枝茯苓胶囊、散结镇痛胶囊等;心脑血管产品线的代表品种有银杏二萜内酯葡胺注射液、天舒胶囊、龙血通络胶囊、益心舒片、大株红景天胶囊、苁蓉总苷胶囊等;骨伤科产品线的代表品种有腰痹通胶囊、复方南星止痛膏、淫羊藿总黄酮胶囊、抗骨增生胶囊等;同时还拥有治疗小儿多发性抽动症的九味熄风颗粒等儿科专用药品。公司是国家技术创新示范企业、国家重点高新技术企业、国家创新型试点企业、国家知识产权示范企业,全国制药工业百强企业。","serverTime":1724542654751,"listedPrice":7,"stockholders":"32912人(较上一季度增加19.04%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康缘药业(600557)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康缘药业(600557)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康缘药业,600557,康缘药业股票,康缘药业股票老虎,康缘药业股票老虎国际,康缘药业行情,康缘药业股票行情,康缘药业股价,康缘药业股市,康缘药业股票价格,康缘药业股票交易,康缘药业股票购买,康缘药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康缘药业(600557)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康缘药业(600557)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}